Details for New Drug Application (NDA): 065243
✉ Email this page to a colleague
The generic ingredient in CLINDAMYCIN HYDROCHLORIDE is clindamycin hydrochloride. There are fifty-five drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the clindamycin hydrochloride profile page.
Summary for 065243
Tradename: | CLINDAMYCIN HYDROCHLORIDE |
Applicant: | Chartwell Molecular |
Ingredient: | clindamycin hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 065243
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 065243
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLINDAMYCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 065243 | ANDA | Chartwell RX, LLC | 62135-764 | 62135-764-01 | 100 CAPSULE in 1 BOTTLE (62135-764-01) |
CLINDAMYCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 065243 | ANDA | Chartwell RX, LLC | 62135-765 | 62135-765-01 | 100 CAPSULE in 1 BOTTLE (62135-765-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 300MG BASE | ||||
Approval Date: | Aug 12, 2005 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 75MG BASE | ||||
Approval Date: | Aug 12, 2005 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Aug 12, 2005 | TE: | RLD: | No |
Complete Access Available with Subscription